Results 241 to 250 of about 47,831 (279)
Some of the next articles are maybe not open access.
Release of N-acetylcysteine and N-acetylcysteine Amide From Contact Lenses
Eye & Contact Lens: Science & Clinical Practice, 2013To investigate the use of contact lenses to release N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) that have frequently used for the treatment of some eye diseases.Three commercial contact lenses were used: Soflens Multi-Focal, 1-Day ACUVUE TruEye, and Frequency 55.
Atabek Yigit E, Ercal N.
openaire +2 more sources
ADVERSE REACTIONS TO N-ACETYLCYSTEINE
The Lancet, 19841 Clinical details of seven patients who suffered adverse reactions to N-acetylcysteine as Parvolex are documented. 2 Skin testing was carried out to diluted Parvolex, and its individual components N-acetylcysteine and ethylenediaminetetra-acetate, in five reacting patients and five patients who had received Parvolex with no ill-effects.
D N, Bateman +2 more
openaire +3 more sources
Hospital Pharmacy, 2004
Each month, subscribers to The Formulary Monograph Service receive five to six well-documented monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada +2 more
openaire +1 more source
Each month, subscribers to The Formulary Monograph Service receive five to six well-documented monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada +2 more
openaire +1 more source
N-Acetylcysteine in Chronic Blepharitis
Cornea, 2002To investigate the effects of N-acetylcysteine (NAC) in chronic posterior blepharitis.This was a prospective randomized, controlled study that included 79 eyes of 40 patients with chronic posterior blepharitis. Routine ophthalmologic examination, Schirmer-1 test, fluorescein break-up time (FBUT), and mucous fern tests were carried out during the first ...
Elvan, Yalçin +3 more
openaire +2 more sources
N-acetylcysteine-cysteine disulfide excretion in the urine following N-acetylcysteine administration
The Journal of Pediatrics, 1969Summary Three patients taking N-acetylcysteine asa topical pulmonary mucolytic agent have been shown to excrete in urine the mixed disulfide of this compound with cysteine. The disulfide gives a positive cyanide-nitroprusside test and may be easily confused by paper chromatography with beta-mercaptolactate-cysteine disulfide, a substance excreted in ...
V E, Shih, J D, Schulman
openaire +2 more sources
1994
Publisher Summary N-Acetylcysteine (NAC) is a thiol-containing compound that has been used in clinical practice for several years. Historically, NAC was introduced for the treatment of congestive and obstructive lung diseases; primarily those associated with hypersecretion of mucus, for example, chronic bronchitis and cystic fibrosis.
Peter Moldéus, Ian A. Cotgreave
openaire +1 more source
Publisher Summary N-Acetylcysteine (NAC) is a thiol-containing compound that has been used in clinical practice for several years. Historically, NAC was introduced for the treatment of congestive and obstructive lung diseases; primarily those associated with hypersecretion of mucus, for example, chronic bronchitis and cystic fibrosis.
Peter Moldéus, Ian A. Cotgreave
openaire +1 more source
Chemico-Biological Interactions, 2014
Geldanamycin (GDN) is a benzoquinone ansamycin antibiotic with anti-proliferative activity on tumor cells. GDN cytotoxicity has been attributed to the disruption of heat shock protein 90 (Hsp90) binding and stabilizing client proteins, and by the induction of oxidative stress with concomitant glutathione (GSH) depletion.
Petr, Mlejnek, Petr, Dolezel
openaire +2 more sources
Geldanamycin (GDN) is a benzoquinone ansamycin antibiotic with anti-proliferative activity on tumor cells. GDN cytotoxicity has been attributed to the disruption of heat shock protein 90 (Hsp90) binding and stabilizing client proteins, and by the induction of oxidative stress with concomitant glutathione (GSH) depletion.
Petr, Mlejnek, Petr, Dolezel
openaire +2 more sources